long half-life and large variability [Regulatives / Guidelines]

posted by dshah  – India/United Kingdom, 2020-08-10 06:18 (644 d 14:56 ago) – Posting: # 21846
Views: 1,872

Hi All!

I believe there are few MR drug with high variability and still USFDA recommends partial or fully replicate design. Mesalamine PSG or
Mesalamine PSG for 800 mg strength
Considering the Mechanism of Action, PK variability, non-Linearity- the study and formultion could indeed be challenging.

Regards,
Dshah

Complete thread:

UA Flag
Activity
 Admin contact
22,074 posts in 4,629 threads, 1,565 registered users;
online 7 (0 registered, 7 guests [including 7 identified bots]).
Forum time: Monday 21:14 CEST (Europe/Vienna)

Rules are for the guidance of wise men
and the blind obedience of fools.    attributed to Solon

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5